[{"Assets_0_Q3_USD":346635000.0,"CommonStockSharesOutstanding_0_Q3_shares":48877297.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-74578000.0,"NetIncomeLoss_1_Q3_USD":-23634000.0,"NetIncomeLoss_3_Q3_USD":-71257000.0,"StockholdersEquity_0_Q3_USD":275652000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20191031"}]